What Is Acute Myeloid Leukemia?

This content has been reviewed and approved by

Hagop M. Kantarjian, MD
Chairman & Professor, Leukemia Department
MD Anderson Cancer Center
University of Texas
 

Acute myeloid leukemia (AML) is a cancer of the blood. AML occurs because too many granulocytes (a type of white blood cell) are produced in bone marrow. Bone marrow is the soft matter inside bones where blood cells are made.

An estimated 13,290 cases of AML will be diagnosed in the United States in 2008, according to the American Cancer Society. AML is the second most commonly diagnosed form of leukemia. It will account for about 30 percent of new U.S. cases of the disease in 2008, according to the ACS.

AML affects mainly older adults, and is more common in men than among women. The average age of a patient with AML is 67, the ACS says. 

Normally, bone marrow cells mature into several different types of blood cells. AML affects the young blood cells (called blasts) that develop into granulocytes. The main function of these white blood cells is to destroy bacteria.

In AML, the blasts fail to mature. These immature cells are called myelocytes. They also become too numerous. Large numbers of these defective cells accumulate in bone marrow and blood. The word “acute” means that the increase in cells caused by AML can occur over a short period of days to weeks.

Abnormal chromosomes (extra chromosomes [DNA] and structural changes in the chromosomes) are found in most AML patients. Chromosomes carry a person’s genetic traits.

This content was last modified on August 11, 2007 .
Latest Acute Myeloid Leukemia News
Birth weight appears associated with leukemia

July 2, 2009 — NEW YORK (Reuters Health) - There may be an association between high birth weight and an increased risk of overall leukemia and acute lymphoblastic leukemia (ALL). The increased risk of acute myeloid leukemia (AML) appears to be associated with the high and low extremes of birth weight.

Most patients want cancer prognosis test

June 16, 2009 — NEW YORK (Reuters Health) - Most patients with a form of eye cancer called choroidal melanoma want to undergo a genetic test that can predict their likely outcome, a small study suggests.

Obesity does not affect leukemia treatment

December 9, 2008 — NEW YORK (Reuters Health) - Obesity has little impact on the success of blood cell transplants for acute myeloid leukemia, the most common reason for performing such transplantations, according to study findings presented at the American Society of Hematology annual meeting in San Francisco.

Select news items provided by Reuters Health